Form 8-K - Current report:
SEC Accession No. 0001564590-21-004526
Filing Date
2021-02-05
Accepted
2021-02-05 16:40:00
Documents
1
Period of Report
2021-02-01
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K flgt-8k_20210201.htm 8-K 29528
  Complete submission text file 0001564590-21-004526.txt   30699
Mailing Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780
Business Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

EIN.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37894 | Film No.: 21596513
SIC: 8071 Services-Medical Laboratories